Chemotherapy Decisions and Patient Experience with the Recurrence Score Assay for Early-Stage Breast Cancer

BACKGROUND: The 21-gene recurrence score assay (RS) stratifies early-stage, estrogen receptor-positive breast cancer by recurrence risk. Few studies have examined how physicians use RS to recommend adjuvant systemic chemotherapy or patient experiences with testing and decision-making. METHODS: We su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Friese, Christopher R., Li, Yun, Bondarenko, Irina, Hofer, Timothy, Ward, Kevin C., Hamilton, Ann S., Deapen, Dennis, Kurian, Allison W., Katz, Steven J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161570/
https://ncbi.nlm.nih.gov/pubmed/27775837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30324
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados